Trials / Completed
CompletedNCT03419910
An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants
An Open-Label, Single-Sequence Study to Investigate the Effects of Cyclosporine on the Pharmacokinetics of BMS-986165 at Steady State in Healthy Male Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is an investigational study of Cyclosporine on the experimental medication BMS-986165 in healthy male participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986165 | Specified dose on specified days |
| DRUG | Cyclosporine | Specified dose on specified days |
Timeline
- Start date
- 2018-03-05
- Primary completion
- 2018-05-04
- Completion
- 2018-05-04
- First posted
- 2018-02-05
- Last updated
- 2020-03-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03419910. Inclusion in this directory is not an endorsement.